Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The recommended starting point for finding UK trials is: NIHR Be Part of Research (bepartofresearch.nihr.ac.uk) the UK's public-facing portal for finding and joining clinical research studies ClinicalTrials.gov and the EU Clinical Trials Register international registries of ongoing studies, including the REDEFINE and TRIUMPH programmes Referral via a GP or specialist to a trial centre In the meantime, men with obesity or type 2 diabetes should be aware that NICE-approved treatments are already available and may offer meaningful clinical benefit: Semaglutide (Wegovy) is approved by NICE (TA875) for weight management in adults with a BMI 35 kg/m (or lower thresholds for certain ethnic groups) and at least one weight-related comorbidity, subject to specialist tier service criteria and duration requirements
In the highest-dose group, the proportions achieving 5%, 10%, and 15% weight loss were substantially greater than with placebo, though precise figures should be verified against the published trial report
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 183,71 per year only 15,31 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Temperature integrity is maintained throughout transit
Compounded semaglutide can be supplied at different concentrations, however, so always confirm the exact ratio printed on your vial label or in your prescriber's instructions before mixing
By reading this article, you acknowledge agreement with this disclaimer
US$ 23.56
US$ 25.76
US$ 29.31
US$ 21.58
US$ 25.30
